Rapid Micro Biosystems Inc - Asset Resilience Ratio
Rapid Micro Biosystems Inc (RPID) has an Asset Resilience Ratio of 8.69% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RPID net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Rapid Micro Biosystems Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see RPID total asset value.
Liquid Assets Composition Over Time
This chart breaks down Rapid Micro Biosystems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Rapid Micro Biosystems Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.08 Million | 8.69% |
| Total Liquid Assets | $5.08 Million | 8.69% |
Asset Resilience Insights
- Limited Liquidity: Rapid Micro Biosystems Inc maintains only 8.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Rapid Micro Biosystems Inc Industry Peers by Asset Resilience Ratio
Compare Rapid Micro Biosystems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Rapid Micro Biosystems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 24.40% | $18.27 Million | $74.85 Million | -10.05pp |
| 2024-12-31 | 34.45% | $33.82 Million | $98.17 Million | -12.79pp |
| 2023-12-31 | 47.24% | $67.77 Million | $143.45 Million | +4.45pp |
| 2022-12-31 | 42.79% | $81.58 Million | $190.65 Million | +36.53pp |
| 2021-12-31 | 6.27% | $15.11 Million | $241.17 Million | -15.16pp |
| 2020-12-31 | 21.43% | $15.00 Million | $70.00 Million | +20.97pp |
| 2019-12-31 | 0.46% | $146.00K | $31.69 Million | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more